傷口治療設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球傷口治療設備市場規模達35億美元，預計2034年將以4.5%的複合年成長率成長，達到54億美元。慢性傷口病例（包括糖尿病足潰瘍、壓瘡和下肢靜脈潰瘍）的增加是市場擴張的主要驅動力之一。這些類型的傷口通常需要更長時間才能癒合，並且需要專門的護理，這為先進的傷口治療設備帶來了巨大的發展機會。糖尿病、肥胖症和血管疾病等疾病的日益流行，也加劇了對負壓傷口治療 (NPWT) 和減壓系統等先進技術的需求，這些技術有助於傷口癒合並減少併發症。

此外，由於皮膚彈性下降、血液循環減慢以及其他與年齡相關的健康狀況，全球老化人口面臨著與傷口癒合相關的日益嚴峻的挑戰。傷口治療設備市場是更廣泛的醫療器材產業的一部分，專注於開發、生產和分銷用於輔助治療和管理急性和慢性傷口（包括手術傷口、燒傷和創傷）的設備。

2024年，負壓傷口治療 (NPWT) 領域佔據市場主導地位，佔據36.2%的市場。此療法對治療慢性傷口尤其有效，尤其是由糖尿病、肥胖和血管疾病等疾病引起的傷口。 NPWT 通過去除多餘液體、減少腫脹和改善受影響組織的血流來加速癒合過程，使其在處理複雜傷口方面尤為重要。其在術後傷口護理中的有效性也促使其應用日益廣泛，因為它有助於降低感染風險並促進手術傷口更快癒合。隨著慢性疾病的持續成長，對 NPWT 的需求將持續成長，使其成為傷口治療設備市場中的關鍵細分領域。

2024年，醫院細分市場佔據54.2%的市場。醫院進行各種外科手術，包括骨科、心血管和一般外科手術，每種手術都可能導致需要高階管理的傷口。傷口治療設備，尤其是NPWT系統和專用敷料，在這些情況下至關重要，可預防感染、延遲癒合和傷口裂開等併發症。全球範圍內手術數量的不斷成長，以及對有效傷口護理的需求，推動了這些設備的需求，從而改善患者預後並縮短康復時間。醫院還可以獲得專業資源，例如傷口護理團隊和先進的醫療設備，這進一步支持了這些先進設備的使用。

預計到2034年，美國傷口治療設備市場規模將達21億美元。這一成長主要源於糖尿病和心血管疾病等慢性疾病的高發生率，這些疾病導致傷口無法癒合的情況日益增加。對先進傷口護理技術（例如非侵入性通氣治療 (NPWT)、氧氣治療設備和傷口監測感測器）的需求正在成長，尤其是在醫院和專科護理中心。美國醫療保健基礎設施完善，擁有廣泛的醫護人員、專科醫生網路以及先進的醫療技術，促進了這些設備的普及，從而有助於改善傷口癒合效果並提升患者的整體護理水平。

全球傷口治療設備市場的一些領先公司包括 3M、B. Braun、Cardinal Health、Medtronic、Medela、Integra LifeSciences、Coloplast、Smith & Nephew、Lohmann & Rauscher、Molnlycke Health Care、Paul Hartmann、DeRoyal Industries、MiMedx、Organogenic 和 Cardinal Health。為了鞏固其在傷口治療設備市場的地位，各公司都優先考慮產品創新，專注於開發先進且更有效的設備，例如改進的 NPWT 系統和多功能傷口護理解決方案。

與醫院、門診中心和醫療保健提供者建立策略合作夥伴關係，對於企業確保其設備覆蓋更廣泛的市場並獲得更廣泛的應用至關重要。企業也正在投資為醫療保健專業人員提供全面的培訓項目，以確保其產品的正確應用和整合。此外，企業正在透過引入生物活性傷口敷料和智慧傷口監測系統等新技術來擴展其產品組合，以增強整體傷口癒合過程。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 每個階段的增值
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 慢性傷口盛行率上升
    • 人口老化日益加劇
    • 傷口護理技術的進步
    • 外科手術和創傷病例增加
  • 產業陷阱與挑戰
    • 先進傷口治療設備成本高昂
    • 發展中國家的認知與採用有限
  • 市場機會
• 成長潛力分析
• 監管格局
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 價格趨勢
  • 按地區
  • 按產品
• 報銷場景
  • 報銷政策對市場成長的影響
• 未來市場趨勢
• 消費者行為分析
• 專利分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 競爭市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 年至 2034 年

• 主要趨勢
• 負壓傷口治療
• 高壓氧治療
• 電刺激裝置
• 壓力釋放裝置
• 其他產品類型

第6章：市場估計與預測：按傷口類型，2021 年至 2034 年

• 主要趨勢
• 慢性傷口
• 急性傷口

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 專科診所
• 其他最終用途

第8章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• B. Braun
• Cardinal Health
• Coloplast
• ConvaTec
• DeRoyal Industries
• Integra LifeSciences
• Lohmann & Rauscher
• Medela
• Medtronic
• MiMedx
• Molnlycke Health Care
• Organogenesis
• Paul Hartmann
• Smith & Nephew
• 3M

The Global Wound Therapy Devices Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 4.5% to reach USD 5.4 billion by 2034. The rise in chronic wound cases, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is one of the primary drivers of market expansion. These types of wounds typically take longer to heal and require specialized care, which opens significant opportunities for advanced wound therapy devices. The growing prevalence of conditions like diabetes, obesity, and vascular diseases has escalated the need for advanced technologies like negative pressure wound therapy (NPWT) and pressure relief systems that aid in wound healing and reduce complications.

Additionally, the aging global population faces increased challenges related to wound healing due to reduced skin elasticity, diminished circulation, and other age-related health conditions. The market for wound therapy devices is part of the broader medical device industry, focusing on the development, production, and distribution of devices designed to aid in the treatment and management of both acute and chronic wounds, including surgical wounds, burns, and traumatic injuries.

The negative pressure wound therapy (NPWT) segment led the market in 2024 with a substantial share of 36.2%. This therapy is particularly effective in treating chronic wounds, especially those caused by conditions such as diabetes, obesity, and vascular diseases. NPWT accelerates the healing process by removing excess fluids, reducing swelling, and improving blood flow to the affected tissue, making it particularly valuable for managing complex wounds. Its effectiveness in post-surgical wound care has also contributed to its growing use, as it helps to reduce the risk of infection and promotes faster healing of surgical wounds. As chronic diseases continue to rise, the demand for NPWT will continue to expand, making it a key segment within the wound therapy devices market.

The hospitals segment held a 54.2% share in 2024. Hospitals perform a wide range of surgical procedures, including orthopedic, cardiovascular, and general surgeries, each of which can result in wounds requiring advanced management. Wound therapy devices, particularly NPWT systems and specialized dressings, are critical in these settings to prevent complications like infections, delayed healing, and dehiscence. The demand for these devices is driven by the increasing number of surgeries being performed worldwide and the need for effective wound care to improve patient outcomes and reduce recovery times. Hospitals also have access to specialized resources, such as wound care teams and advanced medical equipment, which further support the use of these sophisticated devices.

U.S. Wound Therapy Devices Market is expected to reach USD 2.1 billion by 2034. This growth is driven by the high incidence of chronic conditions like diabetes and cardiovascular diseases, which lead to a growing number of non-healing wounds. The demand for advanced wound care technologies such as NPWT, oxygen therapy devices, and wound monitoring sensors is increasing, particularly in hospitals and specialized care centers. The U.S. healthcare infrastructure, with its extensive network of healthcare practitioners, specialists, and access to advanced medical technologies, facilitates the adoption of these devices, contributing to improved wound healing outcomes and better overall patient care.

Some of the leading companies operating in the Global Wound Therapy Devices Market include 3M, B. Braun, Cardinal Health, Medtronic, Medela, Integra LifeSciences, Coloplast, Smith & Nephew, Lohmann & Rauscher, Molnlycke Health Care, Paul Hartmann, DeRoyal Industries, MiMedx, Organogenesis, and Cardinal Health. To solidify their position in the wound therapy devices market, companies are prioritizing product innovation, focusing on developing advanced and more effective devices such as improved NPWT systems and multifunctional wound care solutions.

Strategic partnerships with hospitals, outpatient centers, and healthcare providers are essential for companies to ensure their devices reach broader markets and gain wider adoption. Companies are also investing in comprehensive training programs for healthcare professionals to ensure proper application and integration of their products. Additionally, businesses are expanding their portfolios by introducing new technologies like bioactive wound dressings and smart wound monitoring systems to enhance the overall wound healing process.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Application
  • 2.2.4 End Use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic wounds
    • 3.2.1.2 Growing aging population
    • 3.2.1.3 Advancements in wound care technologies
    • 3.2.1.4 Increased surgical procedures and trauma cases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced wound therapy devices
    • 3.2.2.2 Limited awareness and adoption in developing countries
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Price trends
  • 3.6.1 By region
  • 3.6.2 By product
• 3.7 Reimbursement scenario
  • 3.7.1 Impact of reimbursement policies on market growth
• 3.8 Future market trends
• 3.9 Consumer behaviour analysis
• 3.10 Patent analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Competitive market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Negative pressure wound therapy
• 5.3 Hyperbaric oxygen therapy
• 5.4 Electric stimulation devices
• 5.5 Pressure relief devices
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Wound Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic wounds
• 6.3 Acute wounds

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Mexico
  • 8.5.2 Brazil
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Cardinal Health
• 9.3 Coloplast
• 9.4 ConvaTec
• 9.5 DeRoyal Industries
• 9.6 Integra LifeSciences
• 9.7 Lohmann & Rauscher
• 9.8 Medela
• 9.9 Medtronic
• 9.10 MiMedx
• 9.11 Molnlycke Health Care
• 9.12 Organogenesis
• 9.13 Paul Hartmann
• 9.14 Smith & Nephew
• 9.15 3M